↓ Skip to main content

Green tea polyphenol epigallocatechin 3-gallate in arthritis: progress and promise

Overview of attention for article published in Arthritis Research & Therapy, April 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

news
1 news outlet
twitter
1 X user
facebook
2 Facebook pages

Citations

dimensions_citation
94 Dimensions

Readers on

mendeley
135 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Green tea polyphenol epigallocatechin 3-gallate in arthritis: progress and promise
Published in
Arthritis Research & Therapy, April 2010
DOI 10.1186/ar2982
Pubmed ID
Authors

Salahuddin Ahmed

Abstract

Green tea's active ingredient, epigallocatechin 3-gallate (EGCG), has gained significant attention among scientists and has been one of the leading plant-derived molecules studied for its potential health benefits. In the present review I summarize the findings from some of the most significant preclinical studies with EGCG in arthritic diseases. The review also addresses the limitations of the dose, pharmacokinetics, and bioavailability of EGCG in experimental animals and findings related to the EGCG-drug interaction. Although these findings provide scientific evidence of the anti-rheumatic activity of EGCG, further preclinical studies are warranted before phase clinical trials could be initiated with confidence for patients with joint diseases.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 135 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 1%
Malaysia 1 <1%
Norway 1 <1%
Unknown 131 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 20 15%
Student > Ph. D. Student 19 14%
Student > Master 18 13%
Student > Bachelor 17 13%
Student > Doctoral Student 8 6%
Other 26 19%
Unknown 27 20%
Readers by discipline Count As %
Medicine and Dentistry 42 31%
Agricultural and Biological Sciences 19 14%
Pharmacology, Toxicology and Pharmaceutical Science 13 10%
Nursing and Health Professions 9 7%
Chemistry 5 4%
Other 12 9%
Unknown 35 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 September 2023.
All research outputs
#3,026,185
of 25,373,627 outputs
Outputs from Arthritis Research & Therapy
#615
of 3,381 outputs
Outputs of similar age
#11,613
of 104,890 outputs
Outputs of similar age from Arthritis Research & Therapy
#6
of 38 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,381 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 104,890 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 38 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.